These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


373 related items for PubMed ID: 19295150

  • 1. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
    Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D'Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, Bernardi G, Cecconi F, Battistini L, Furlan R, Martino G.
    J Neurosci; 2009 Mar 18; 29(11):3442-52. PubMed ID: 19295150
    [Abstract] [Full Text] [Related]

  • 2. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, Hornstein E, Bozzoni I, Presutti C, Centonze D.
    J Neurosci; 2017 Jan 18; 37(3):546-561. PubMed ID: 28100738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.
    Morquette B, Juźwik CA, Drake SS, Charabati M, Zhang Y, Lécuyer MA, Galloway DA, Dumas A, de Faria Junior O, Paradis-Isler N, Bueno M, Rambaldi I, Zandee S, Moore C, Bar-Or A, Vallières L, Prat A, Fournier AE.
    Brain; 2019 Oct 01; 142(10):2979-2995. PubMed ID: 31412103
    [Abstract] [Full Text] [Related]

  • 7. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Durose WW, Shimizu T, Li J, Abe M, Sakimura K, Chetsawang B, Tanaka KF, Suzumura A, Tohyama K, Ikenaka K.
    J Neurochem; 2019 Feb 01; 148(3):413-425. PubMed ID: 30152001
    [Abstract] [Full Text] [Related]

  • 8. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S, Verbeek M, Gomez CD, Bisht K, Lee B, Benoit L, Sharkey KA, Benediktsson A, Tremblay ME, Pittman QJ.
    J Neurosci; 2018 Oct 17; 38(42):9019-9033. PubMed ID: 30185466
    [Abstract] [Full Text] [Related]

  • 9. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR.
    Lab Invest; 2010 May 17; 90(5):774-86. PubMed ID: 20157291
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis.
    Alrashdi B, Dawod B, Schampel A, Tacke S, Kuerten S, Marshall JS, Côté PD.
    J Neuroinflammation; 2019 Nov 13; 16(1):215. PubMed ID: 31722722
    [Abstract] [Full Text] [Related]

  • 14. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
    Brown DA, Sawchenko PE.
    J Comp Neurol; 2007 May 10; 502(2):236-60. PubMed ID: 17348011
    [Abstract] [Full Text] [Related]

  • 15. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J, Planche V, Dubourdieu N, Oliveira A, Séré A, Ducourneau EG, Tible M, Maitre M, Lesté-Lasserre T, Nadjar A, Desmedt A, Ciofi P, Oliet SH, Panatier A, Tourdias T.
    Neurobiol Dis; 2021 Dec 10; 160():105533. PubMed ID: 34673149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
    Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D.
    J Neuroimmune Pharmacol; 2013 Jun 10; 8(3):651-63. PubMed ID: 23370991
    [Abstract] [Full Text] [Related]

  • 18. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Musella A, Gentile A, Guadalupi L, Rizzo FR, De Vito F, Fresegna D, Bruno A, Dolcetti E, Vanni V, Vitiello L, Bullitta S, Sanna K, Caioli S, Balletta S, Nencini M, Buttari F, Stampanoni Bassi M, Centonze D, Mandolesi G.
    Cells; 2020 May 22; 9(5):. PubMed ID: 32455907
    [Abstract] [Full Text] [Related]

  • 19. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW.
    Mol Neurobiol; 2018 Apr 22; 55(4):3007-3020. PubMed ID: 28456941
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.